Prevence recidiv oparu poliovakcínou

Prevention of Herpes by Poliovaccine

In the course of 20 years in collaboration with dermatologists and doctors attending adolescents 75patients were treated suffering for at least four years from 10 relapses of herpes labialis or genitalisevery year. The usual treatment mitigated only temporarily their complaints but had no effect onthe frequency of relapses. Two thirds of the patients had immunological examinations, in half ofthem shortage of IgA was found. Only 12 subjects had during comprehensive immunologicalexaminations normal results. After 3–4 years immunomodulation with poliovaccine in rare instan-ces combined with other immune preparations, the condition improved in 67 of 69 patients (97%),in two (3%) it remained unaltered. The procedure involved restricted exposure to tobacco smoke,alcohol, UV rays and sleep deficiency. After a comprehensive immunological examination immuno-modulation with levamisol was started. This was followed by the administration of 2–3 drops ofpoliovaccine, at first every month, when the complaints receded the interval of vaccin e administra-tion was prolonged. When the complaints persisted the immunity of the organism was promoted byprotection from influenza (vaccination, Remantadin) and other respiratory infections (Isoprinosin,Modimunal) and the general resistance was reinforced (Biostim).The mentioned procedure should be reserved for subjects with herpes persisting for a long time andwith frequently relapsing herpes.

Key words:
herpes labialis and genitalis –⁠ immunomodulation –⁠ poliovaccine.